Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Costenbader

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Arthritis Care & Research|October 5, 2010
What do pesticides, farming, and dose effects have to do with the risk of developing connective tissue disease?Karen Costenbader, Francine Laden
Expert Review of Clinical Immunology|January 25, 2022
Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosusMartin Aringer, Karen Costenbader, Sindhu R Johnson
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?Elena M Massarotti, Heather G Allore, Karen Costenbader
Journal of Autoimmunity|June 20, 2022
Advances in SLE classification criteriaMartin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|March 4, 2020
Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|September 20, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS' by Assan <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Arthritis and Rheumatism|June 4, 2005
Does practice make perfect?Jeffrey N Katz, Karen Costenbader, Daniel H Solomon, et al.
Annals of the Rheumatic Diseases|September 12, 2021
Response to: Correspondence on "European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance" by Bossuyt <i>et al</i>Martin Aringer, Karen Costenbader, Nicolai Leuchten, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Arthritis Care & Research|October 5, 2010
What do pesticides, farming, and dose effects have to do with the risk of developing connective tissue disease?Karen Costenbader, Francine Laden
Expert Review of Clinical Immunology|January 25, 2022
Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosusMartin Aringer, Karen Costenbader, Sindhu R Johnson
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?Elena M Massarotti, Heather G Allore, Karen Costenbader
Journal of Autoimmunity|June 20, 2022
Advances in SLE classification criteriaMartin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|March 4, 2020
Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|September 20, 2019
Response to: 'New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS' by Assan <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|December 22, 2019
Response to: 'Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang <i>et al</i>Martin Aringer, Karen Costenbader, Thomas Dörner, et al.
Arthritis and Rheumatism|June 4, 2005
Does practice make perfect?Jeffrey N Katz, Karen Costenbader, Daniel H Solomon, et al.
Annals of the Rheumatic Diseases|September 12, 2021
Response to: Correspondence on "European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance" by Bossuyt <i>et al</i>Martin Aringer, Karen Costenbader, Nicolai Leuchten, et al.
Pageof 5